Horizon Petroleum Receives Resource Report for Ledieux Permit in France
Horizon Petroleum Ltd. (the “Company” or “Horizon”) (TSXV: HPL) is pleased to report the results of an independent Resource Report prepared by Apex Energy Consultants Inc. (the “Apex Report”), of Calgary, Alberta, on the Company’s recently-acquired and 100%-owned Ledieux Exploration Permit (the “Permit”) in the Aquitaine Basin of south-western France. The Apex Report has been prepared in accordance with the standards contained in the Canadian Oil and Gas Evaluation Handbook reserve definitions that are consistent with the standards of National Instrument 51-101 ("NI 51-101"), to describe and quantify the Contingent Resources and Prospective Resources contained within the Permit.
The valuation was limited to the following scope:
- Presenting the discovered Contingent Conventional Natural Gas Resources in the Saucède -1 gas discovery in the Permit; and
- Undiscovered Prospective Conventional Natural Gas Resources in the undrilled structures of the Permit, Aquitaine Basin, France.
The key highlights of the Report are as follows:
- Unrisked Best Estimate Contingent Conventional Natural Gas Resources of 718.7 billion cubic feet.
- Net Present Value of the Risked Contingent Conventional Natural Gas Resources, discounted at 10%, of US$1.116 billion.
Ledieux Exploration Permit, France
Horizon holds a 100% interest in the Permit, which is located in the Aquitaine Basin of south-western France. The basin contains the largest natural gas fields in France: Lacq and Meillon, which combined have produced 11 TCF of gas to date. Hydrocarbons were sourced from the Lower Jurassic aged shales and marls, and have migrated into Jurassic and Cretaceous aged naturally fractured carbonate reservoirs contained in folded thrust sheets of the Pyrenean fold belt.
Eleven wells have been drilled in the Permit, with two of those wells testing hydrocarbons. Saucede-1 drilled in 1978 by Esso was a gas discovery flowing an average 9 MMscf/d over 19 days. It was placed on production 1981- 1985 and again in 1988 to 1993. The well produced a cumulative 1.85 BCF of gas from Lower Cretaceous and Jurassic aged naturally fractured carbonate reservoirs between 4,200 and 5,410 meters below sea level. Reservoir engineering analysis has indicated significant wellbore damage, caused by overweight drilling fluids and poor completion practices which could have resulted in poor well performance.
A number of leads have also been identified in different thrust sheets that have similar characteristics to the Saucede gas discovery at shallower depths that provide significant upside potential.
The Apex Report
The Apex Report documents the results of its independent evaluation with Tables summarizing the total Company gross and net, unrisked and risked Contingent and Prospective Resource volumes. The volumes were estimated using stochastic techniques.
The “A-2, A-3 and A-4” Reservoirs contain Contingent Conventional Natural Gas Resources as defined in the Canadian Oil and Gas Handbook and summarized below. Based upon Apex’s evaluation, the Saucède-1 well was a discovery well and is located on the downdip edge of an undeveloped gas field. The well was placed on production at an initial rate of 1.5 MMscfd, producing a total of 1.85 Bcf of conventional sweet gas before being shut in at a rate of approximately 0.46 MMscfd. The poor production performance of the well was attributed to the poor operating and completions practices when the well was drilled and tested. Based on the reservoir test data, Apex estimate an initial production rate of 25 – 30 MMscf/d per well with an appropriate completion.
The Saucède-1 well is shown by seismic data to be part of a large structure comprising three separate thrust sheets, and additional Contingent Resources were assigned to the remainder of the A2, A-3 and A-4 reservoirs penetrated by the Saucede-1 well. The main contingencies relate to the future successful completion of new production wells, the development of the gas processing infrastructure and the negotiation to access the regional infrastructure, and gas marketing agreements to sell the natural gas. Approximately 60% of the Contingent Resources are contained in the A2 reservoir between 4,200m and 4,800m. Horizon plans to target the A2 reservoir for an initial development on the Saucede discovery with the deeper A3 and A4 reservoirs being targeted later once cash flow has been established from the A2 reservoir.
The Permit contains other prospects that will require drilling to test the Undiscovered Prospective Resources. There are sufficient geological and geophysical interpretations that in the opinion of Apex Energy Consultants allow for the estimation of a Prospective Resource as defined in the body of the Report:
Prospective Resources are those quantities of petroleum estimated, as of a given date, to be potentially recoverable from undiscovered accumulations by application of future development projects. There is no certainty that any portion of the Resources will be discovered. If discovered, there is no certainty that it will be commercially viable to produce any portion of the resources.
Contingent Resources are those quantities of petroleum estimated, as of a given date, to be potentially recoverable from known accumulations, but the applied projects are not yet considered mature enough for commercial development due to one or more contingencies.
A BOE conversion ratio of 6 Mscf: 1 barrel has been used within the Report. This conversion ratio is based upon an energy equivalency conversion method primarily applicable at the burner tip and does not represent a value equivalency at the wellhead.
Summary of the Report
The Report focuses on the Saucède – 1 gas discovery well, which was drilled to sufficient depth to intersect prospective horizons in the Permit. It was the only well in the Permit to produce from the naturally fractured carbonate reservoirs in the thrust sheets referred to as the A2, A3 and A4 thrust sheets. While the well was successfully drilled it was not successfully completed which had negative impact on the eventual production of conventional natural gas from the well. Conventional Natural Gas refers to natural gas that can be produced from reservoirs using traditional drilling, pumping and compression techniques.
Contingent Resources and Prospective Resources are summarized in Tables 1, and 3 below. The resources are sub-classified as “Development Unclarified” as the project is currently under active evaluation. Apex completed an economic analysis of the Risked Contingent Resources the results of which are summarized in Table 2.
Gross (100% WI) Conventional Natural Gas Volumes (Bcf)
Unrisked Contingent Conventional Natural
|Reservoir||Low Estimate||Best Estimate||High Estimate||Best Estimate||Best Estimate|
|Discounted NPV of Future Cash Flow (US$ MM)|
Prospective Resources were assigned to two undrilled structures in the Permit that were not previously tested by drilling. These present significant upside potential to the Permit:
|Gross (100% WI) Conventional Natural Gas Volumes (Bcf)|
Unrisked Prospective Recoverable
|Low Estimate||Best Estimate||High Estimate||Best Estimate||Best Estimate||Best Estimate|
Exploration and Development Strategy for the Permit
The French government has recently stated that it will no longer issue exploration permits. As well, the extension of current concessions will be gradually limited until they are phased out by 2040. The French government has also recently stated that it plans to pass legislation this year to phase out all oil and gas exploration and production by 2040.
This will not impact the Permit because it is an existing exploration permit. Furthermore, the Company intends to meet its financial commits on the Permit, which would ensure its continuance. Horizon management will be meeting with representatives of the BEPH (Bureau Exploration-Production des Hydrocarbures) in Paris in October, to discuss the Company's plans for its Permit.
The Permit presents an opportunity to appraise and potentially develop Contingent Conventional Natural Gas Resources in a basin with ample existing gas infrastructure, and a well-developed gas market. Management and Directors of Horizon have expertise and experience in appraising, developing and monetizing naturally fractured reservoirs around the world with a number of oil and gas companies. Horizon’s strategy is to leverage that experience to target, acquire, develop and monetize these permits as well as similar gas resources in Europe. The scale of the target resource plays is such that they are immaterial to the large independents and major oil and gas companies but highly material to junior independents that have the technical and operating expertise and experience. The permits in France represent the first step in executing this strategy, and management has identified a number of potential follow up opportunities with significant undeveloped gas resources.
About Horizon Petroleum Ltd.
Calgary-based Horizon is focused on the appraisal and development of oil & gas reserves internationally. The Management and Board of Horizon consist of oil & gas professionals with significant international experience.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This press release contains "forward-looking statements" or "forward-looking information" (collectively referred to herein as "forward-looking statements") within the meaning of applicable securities legislation. Such forward-looking statements include, without limitation, forecasts, estimates, expectations and objectives for future operations that are subject to a number of assumptions, risks and uncertainties, many of which are beyond the control of Horizon. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects", "plans", "anticipates", "believes", "intends", "estimates", "projects", "potential" and similar expressions, or that events or conditions "will", "would", "may", "could" or "should" occur or be achieved. This press release contains forward-looking statements pertaining to, among other things Horizon’s ability to meet its obligations regarding the Permit and otherwise maintain the Permit and the furtherance of Horizon’s European acquisition and development strategy.
Forward-looking information is based on current expectations, estimates and projections that involve a number of risks, which could cause actual results to vary and in some instances to differ materially from those anticipated by Horizon and described in the forward-looking information contained in this press release.
Certain of the "risk factors" that could cause actual results to differ materially from the Company's forward-looking statements in this press release include, without limitation, changes of laws or regulations; the ability to implement business strategies or to pursue business opportunities, whether for economic or other reasons; status of the world markets, prices and price volatility; state of capital markets and ability to raise capital; litigation; the commercial and economic viability of the extraction technology the ability to Horizon to extract resources or develop on the Permit, reliance on suppliers, contractors, consultants and key personnel, risks associated with compliance with environmental protection laws and regulations.
Although Horizon believes that the material factors, expectations and assumptions expressed in such forward-looking statements are reasonable based on information available to it on the date such statements were made, no assurances can be given as to future results, levels of activity and achievements and such statements are not guarantees of future performance.
Horizon Petroleum Ltd.
Dr. David Winter, +1-403-984-2444
President & CEO
David R. Robinson, +1-403-399-9047
VP Business Development
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Pierre Fabre & Array BioPharma Announce a 62% Observed OS at One Year from the Phase 3 BEACON CRC Safety Lead-In of the Combination of Encorafenib, Binimetinib and Cetuximab in BRAF-Mutant CRC at the ESMO GI Congress23.6.2018 11:00 | Pressemelding
Not intended for UK- and US-based media Pierre Fabre and its partner Array BioPharma Inc. today announced updated safety and efficacy results, including OS, from the safety lead-in of the Phase 3 BEACON CRC trial evaluating the triplet combination of encorafenib, a BRAF inhibitor, binimetinib, a MEK inhibitor and cetuximab, an anti-EGFR antibody, in patients with BRAF V600E -mutant metastatic colorectal cancer (CRC). The results showed that, at the time of analysis, the OS data were fully mature through 12.6 months and that the median OS had not yet been reached. The one-year overall survival rate for this cohort was 62%. These data were presented in an oral presentation on Saturday, June 23, at the ESMO 20th World Congress on Gastrointestinal Cancer in Barcelona, Spain. The median progression-free survival (mPFS) for patients treated with the triplet was 8 months [95% CI 5.6-9.3] and is similar between patients receiving one prior line of therapy and patients receiving two prior lines
Compelling Data for LONSURF® (trifluridine/tipiracil) in Metastatic Colorectal Cancer Presented at ESMO’s World Congress on Gastrointestinal Cancer by Servier and Taiho23.6.2018 08:10 | Pressemelding
Servier and Taiho Pharmaceutical Co., Ltd. today announced that the TASCO-1 trial demonstrated promising results for LONSURF® (trifluridine/tipiracil) in combination with bevacizumab in patients with previously untreated metastatic colorectal cancer (mCRC) who are not suitable for intensive treatment, with a median progression-free survival (PFS) of 9.2 months (ranging from 7.6 to 11.5 months). A second non-comparative arm in the trial, evaluated the outcome of patients treated with the current standard of care of capecitabine in combination with bevacizumab. The median PFS of this arm was 7.8 months (ranging from 5.5 to 10.1 months). “Colorectal cancer is the third most common cancer in the world. While there has been some progress in treatment, there are still few options for patients with metastatic disease who are not suitable for intensive treatment,” said Professor Eric Van Cutsem, Head of Digestive Oncology at the University of Leuven, Belgium. “These compelling results suggest
Softomotive and Accelerate RPA Partner to Help Enterprises Achieve Faster Time to Value from RPA22.6.2018 15:13 | Pressemelding
Softomotive, a world–class Robotic Process Automation (RPA) technology provider offering best time to value and affordability for all sizes and types of enterprises, is pleased to announce a strategic partnership with AccelerateRPA, a high calibre professional services provider of trained and certified RPA Consultants within Robotic Process Automation. This partnership means that customers and end users of Softomotive’s software, will have additional knowledgeable and professional guidance available to help achieve significant value quickly from their investment in RPA. Companies who are looking to implement Softomotive’s RPA product suite (WinAutomation and ProcessRobot software) will now have direct access to AccelerateRPA’s highly skilled consultants and Developers. Further, AccelerateRPA has also become a licensed reseller of Softomotive’s products, offering customers a single point of contact for delivering both RPA software and services. Ashley Hudson, Director of AccelerateRPA,
Ascend Performance Materials Announces Price Increase for Intermediate Materials22.6.2018 14:00 | Pressemelding
Ascend Performance Materials announced today a price increase for its intermediate materials. The price increase will take effect globally on July 1, 2018, and includes the following terms: Material Price Increase Terms Hexamethylene diamine (HMD) $0.17/lb. • As contracts allow. • Non-contract business – price determined on an order-by-order basis. Acrylonitrile (AN) $0.20/lb. • As contracts allow. • Non-contract business – price determined on an order-by-order basis. Customers should contact their local sales representative for additional information. About Ascend Performance Materials Ascend Performance Materials is a global premium provider of high-quality plastics, fibers and chemicals and is the world’s largest integrated producer of PA66 resin. Headquartered in Houston, Texas, Ascend has eight global locations, including five fully-integrated manufacturing facilities located in the southeastern United States, all dedicated to the innovation and safe production of nylon 6,6. With
Different Countries, Different Customs: Get Ready for the Motorbike Holidays with Moto-tyres.co.uk22.6.2018 13:41 | Pressemelding
Pack your bags, close the boot and get away on holiday? When you start your holidays on a motorcycle, you usually have to consider a few things more when getting ready for your trip. The right preparation is therefore a must. So that nothing stands in the way of a smooth journey, Moto-tyres.co.uk has put together some tips for your next trip. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180622005345/en/ Different countries, different customs: get ready for the motorbike holidays with Moto-tyres.co.uk (Photo: Business Wire) Whether a weekend trip or extended adventure, it all depends on the right equipment. Functional clothing, protectors and rain protection are a must on long trips. Wearing a suitable motorcycle helmet is a legal requirement almost everywhere. However, there are also very different rules and regulations for motorbike equipment and accessories depending on the destination, and you should familiarise yoursel
Boehringer Ingelheim bolsters biologics research and development with 230 million euro investment in new development center22.6.2018 12:00 | Pressemelding
Today Boehringer Ingelheim announced a 230 million euro investment into a new Biologicals Development Center (BDC) at the company’s Research and Development site in Biberach, Germany during the foundation stone laying for the new center. “The BDC is another key building block supporting the company’s long-term strategy for increasing the pipeline’s share of biologicals. This is particularly driven by two of our core areas, immune oncology and immunology,” says Dr. Fridtjof Traulsen, Corporate Senior Vice President Development at Boehringer Ingelheim. “The share of new biological entities in Boehringer Ingelheim’s research pipeline has been consistently increasing over the past few years and has now reached forty percent.” The BDC will help to maximize synergies by integrating biologicals analytical and process development as well as manufacturing for clinical studies into one seamless unit, while at the same time increasing development capacity. Following a staggered launch beginning i